Evidence map›Paper›PMID 40985690›Full record

ArticleGenomics, proteomics & bioinformatics2025

A Model for the Development of Alzheimer's Disease.

Zhenyu Huang 黄振羽, Xuechen Mu 穆学琛, Qiufen Chen 陈秋芬, Lingli Zhong 钟灵丽, Jun Xiao 肖隽, Chunman Zuo 左春满, Ye Zhang 张晔, Bocheng Shi 石博诚, Yingwei Qu 曲寅玮, Renbo Tan 谭任博 and 3 more

Abstract read
In one paragraph

Article in Genomics, proteomics & bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zhenyu Huang 黄振羽College of Computer Science and Technology, Jilin University, Changchun 130012, China.ORCID 0009-0009-0029-1729
Xuechen Mu 穆学琛Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0000-0003-1006-2830
Qiufen Chen 陈秋芬Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0000-0002-8752-571X
Lingli Zhong 钟灵丽Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0009-0007-0536-411X
Jun Xiao 肖隽College of Computer Science and Technology, Jilin University, Changchun 130012, China.ORCID 0000-0002-4940-0174
Chunman Zuo 左春满Institute of Artificial Intelligence, Donghua University, Shanghai 201620, China.ORCID 0000-0001-5681-0887
Ye Zhang 张晔The First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang 110001, China.ORCID 0000-0002-7238-6964
Bocheng Shi 石博诚Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0009-0008-4362-2615
Yingwei Qu 曲寅玮College of Computer Science and Technology, Jilin University, Changchun 130012, China.ORCID 0009-0008-5232-5284
Renbo Tan 谭任博Northeast Asia Research Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130012, China.ORCID 0000-0003-4446-1610
Long Xu 许龙Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0000-0002-4790-0466
Renchu Guan 管仁初College of Computer Science and Technology, Jilin University, Changchun 130012, China.ORCID 0000-0002-7162-7826
Ying Xu 徐鹰Systems Biology Lab for Metabolic Reprogramming, Department of Human Genetics and Cell Biology, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.ORCID 0000-0002-7856-3343

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intracellular alkalosis and extracellular acidosis are well-established characteristics of Alzheimer's disease (AD). We present a computational analysis and modeling of transcriptomic data of AD tissues, aiming to understand their causes and consequences. Our analyses have revealed that (1) persistent mitochondrial alkalization is due to chronic inflammation coupled with elevated iron and copper metabolisms; (2) the affected cells activate multiple acid-producing metabolisms to keep the mitochondrial pH stable for survival; (3) the most significant one is the continuous import and hydrolysis of glutamine to glutamate, NH3, and H+, resulting in persistent release of glutamate, an excitatory neurotransmitter, into the extracellular space; (4) this leads to persistent hyperexcitability of the nearby neurons, resulting in their continuous firing and release of H+-rich synaptic vesicles; (5) the H+ is neutralized by bicarbonates released by the neighboring astrocytes in normal tissues, which could not keep up with the increased the release of H+ in their discharge rates of bicarbonates in AD tissues, leading to progressively increased extracellular acidosis and ultimately cell death; and (6) multiple extensively studied AD-associated phenotypes, including Aβ aggregates and tau fibers, are induced to help to alleviate the pH imbalances and beneficial to cell survival in the early phase of AD, which gradually become contributors to the AD development. Each step in this model is largely supported by published studies. Overall, we have developed a fundamentally novel and systems-level view of how AD may have evolved.

Indexed as

Alzheimer DiseaseModels, BiologicalAnimalsGlutamic AcidHumansHydrogen-Ion ConcentrationMitochondriaTranscriptomeGlutamic AcidAlzheimer’s diseaseExtracellular acidosisIntracellular alkalosisMetabolic reprogrammingTranscriptomic analysis

Identifiers

PMID40985690
PMCPMC13365266

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.